Ningkang Ruizhu
About:
Rezubio Pharmaceuticals is a targeted drugs developer.
Website: https://www.rezubio.com
Top Investors: Zhuhai Science & Technology Venture Capital, RiverHead Capital, Hanne Capital, Sunshine Capital, GF Qianhe Investment
Description:
Rezubio Pharmaceuticals is a biotech company that focuses on technologies to deliver drugs to diseased tissues or organs, maximizing the desired efficacies while minimizing the adverse effects. They concentrate on oncology, metabolic disease, and immunology as specific disease areas.
Total Funding Amount:
$11.5M
Headquarters Location:
Zhuhai, Guangdong, China
Founded Date:
2019-01-01
Founders:
Yusheng Xiong
Number of Employees:
11-50
Last Funding Date:
2023-10-20
IPO Status:
Private
Industries:
© 2025 bioDAO.ai